1,048
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients

, , , , , , , , & show all
Pages 69-75 | Received 12 Jun 2023, Accepted 11 Oct 2023, Published online: 23 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.